Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/1999
05/12/1999EP0915086A1 Phenylsulfonamide derivatives
05/12/1999EP0914829A1 Preventives and/or remedies for multiple organ failure
05/12/1999EP0914828A2 Use of des-aspartate-angiotensin I
05/12/1999EP0914821A2 Method for diagnosis of atherosclerosis involving measurement of NADPH oxidase activity
05/12/1999EP0914605A1 Molecular model for vla-4 inhibitors
05/12/1999EP0914453A1 HUMAN INTERLEUKIN-1j AND ANTAGONISTS THEREOF
05/12/1999EP0914444A1 Vectors comprising sar elements
05/12/1999EP0914430A2 Polynucleotides from human fetal brain encoding secreted proteins
05/12/1999EP0914417A2 Human dnase ii
05/12/1999EP0914341A1 Antagonists of intestinotrophic glp-2 peptides
05/12/1999EP0914336A2 Secreted proteins
05/12/1999EP0914319A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
05/12/1999EP0914158A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
05/12/1999EP0914132A1 Eutrophic drug compositions based on transferrin glycans
05/12/1999EP0914124A1 ANTITHROMBOTIC AND ANTIATHEROGENIC PHARMACEUTICAL COMPOSITION INCLUDING A THIENOPYRIDINE DERIVATIVE AND AN HMG-CoA-REDUCTASE INHIBITOR
05/12/1999EP0914122A1 Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone
05/12/1999EP0914111A2 Method for the prevention and treatment of cachexia and anorexia
05/12/1999EP0914102A1 Compositions and methods for treating or preventing diseases of body passageways
05/12/1999EP0772438B1 Use of benzothiophenes for the preparation of a medicament for reducing scarring in wound healing
05/12/1999EP0754230B1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
05/12/1999EP0735888A4 Purine compositions and methods for administration
05/12/1999EP0696281B1 Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
05/12/1999EP0628046B1 Triazolopyrimidin derivatives as antiotensin ii receptor antagonists
05/12/1999EP0481000B1 Receptors for fibroblast growth factors
05/12/1999CN1216547A Proton pump inhibitor
05/12/1999CN1216545A Farnesyl transferase inhibitors
05/12/1999CN1216544A Novel N-7-heterocyclyl pyrrolo [2,3-D] pyridines and their use
05/12/1999CN1216531A Indole derivatives useful as endothelin receptor antagonists
05/12/1999CN1216527A Process for scavenging thiols
05/12/1999CN1043347C 2-heteroaryl-5,11-dihydro-6H-dipyrido [3,2-b: 2',3'-3]-3] [1,4] diazepines and their use in the prevention or treatment of HIV infection
05/12/1999CN1043344C New heterocyclic compounds, preparing method, pharmaceutical composition and use
05/11/1999US5902831 Administering reduced nicotinamide-adenine dinucleotide phosphate oxidase inhibitor to treat condition resulting from endothelial hyperpermeability
05/11/1999US5902824 Phenyldihydrobenzofuranes
05/11/1999US5902819 Triazole derivatives
05/11/1999US5902814 Treating psychotic disorder, intellectual disorders and anxiety, such as attention deficit hyperactivity disorder and schizophrenia
05/11/1999US5902813 Modulators of the benzodiaxepine receptor ot the gamma-butyric acid(a) receptor complex; anxiolytic, antiepileptic and -convulsant agents; sleep and memory disorders
05/11/1999US5902803 5H,10H-imidazo 1,2-a!indeno 1,2-e!pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives
05/11/1999US5902798 Method of promoting dermal wound healing with chitosan and heparin or heparin sulfate
05/11/1999US5902791 Metalloproteinase inhibitors
05/11/1999US5902610 Formulations and methods of use of 2,2'-dithio-bis-ethane sulfonate
05/11/1999US5902458 Method of separating sesamin analogues
05/11/1999CA2001889C Zinc cysteate, its preparation and uses in pharmacy and cosmetology
05/07/1999CA2253064A1 Nef action inhibitor
05/06/1999WO1999022243A1 148 human secreted proteins
05/06/1999WO1999021875A1 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies
05/06/1999WO1999021862A1 Sarcodictyin and eleutherobin useful for stabilising microtubules
05/06/1999WO1999021860A1 Phenanthroline derivatives
05/06/1999WO1999021858A1 Synthesis of swainsonine salts
05/06/1999WO1999021857A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
05/06/1999WO1999021846A1 Cyclopentene derivatives useful as antagonists of the motilin receptor
05/06/1999WO1999021845A2 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
05/06/1999WO1999021843A1 4, 5-diaryloxazole compounds
05/06/1999WO1999021836A1 Substituted isoquinoline derivatives and their use as anticonvulsants
05/06/1999WO1999021831A1 Tricyclic compounds as cgmp-pde inhibitors
05/06/1999WO1999021590A1 Gene therapy for stimulation of angiogenesis
05/06/1999WO1999021581A1 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration
05/06/1999WO1999021576A1 Cd8 as an inhibitor of the cellular immune system
05/06/1999WO1999021574A2 Enhancement of morphogen activity
05/06/1999WO1999021572A1 Soluble mhc complexes and methods of use thereof
05/06/1999WO1999021570A1 Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
05/06/1999WO1999021567A1 Pharmaceutical compositions for oral administration of molecular iodine
05/06/1999WO1999021565A1 Nutritional supplement for cerebral metabolic insufficiencies
05/06/1999WO1999021564A1 Cyclic phosphonate ester inhibitors of microsomal triglyceride transfer protein and method
05/06/1999WO1999021562A1 Treatment of female sexual dysfunction
05/06/1999WO1999021559A1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS
05/06/1999WO1999021557A1 Antagonists of gonadotropin releasing hormone
05/06/1999WO1999021553A1 Antagonists of gonadotropin releasing hormone
05/06/1999WO1999021552A1 Use of non-immunosuppressive compounds for promoting nerve regeneration
05/06/1999WO1999021549A1 Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
05/06/1999WO1999021548A1 Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
05/06/1999WO1999021546A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS
05/06/1999WO1999021542A2 Methods for modulating macrophage proliferation using polyamine analogs
05/06/1999WO1999021540A2 Method of reducing craving in mammals
05/06/1999WO1999021539A1 Method for treating disease-related or drug-induced dyskinesias
05/06/1999WO1999010516A3 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
05/06/1999WO1999009156A3 Protease-related protein
05/06/1999WO1999007407A9 Heparin-binding growth factor (hbgf) polypeptides
05/06/1999EP0913396A2 Sulphonamide substituted benzopyran derivatives, process of preparation, their use as medicines and pharmaceutical compositions containing them
05/06/1999EP0913161A2 Diagnostic agent for diabetes
05/06/1999EP0913156A1 Methods for treating hypercoagulable states or acquired protein C deficiency
05/06/1999EP0913155A2 Pharmaceutical formulation for treating liver disorders
05/06/1999EP0912741A2 T-cell selective interleukin-4 agonists
05/06/1999EP0912735A2 Secreted proteins and polynucleotides encoding them
05/06/1999EP0912602A1 Method of treating beta-amyloid peptide associated conditions using trh
05/06/1999EP0912601A1 Suppression of immune response via inhibition of cathepsin s
05/06/1999EP0912578A1 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
05/06/1999EP0912575A1 Improved methods for the synthesis of chemical compounds having pde-iv inhibitory activity
05/06/1999EP0912572A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
05/06/1999EP0912570A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
05/06/1999EP0912568A1 Novel imidazopyridines
05/06/1999EP0912567A1 Carboline derivatives
05/06/1999EP0912558A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
05/06/1999EP0912554A1 Indoline derivatives useful as 5-ht-2c receptor antagonists
05/06/1999EP0912551A1 Somatostatin agonists and antagonists
05/06/1999EP0912545A1 Hydroxamic acid based collagenase inhibitors
05/06/1999EP0912542A1 Oxocoumarin and barbituric acid derivates, their preparation and their use as ligand inhibitors of a corticotropin-releasing factor (crf) and/or a crf-binding protein complex
05/06/1999EP0912534A1 Muscarinic antagonists
05/06/1999EP0912533A1 Alkylaminobenzothiazole and -benzoxazole derivatives
05/06/1999EP0912521A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
05/06/1999EP0912520A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
1 ... 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 ... 1564